WallStreetZenWallStreetZen

NYSE: CAH
Cardinal Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CAH

Based on 12 analysts offering 12 month price targets for Cardinal Health Inc

Min Forecast
$260.00-6.07%
Avg Forecast
$286.00+3.33%
Max Forecast
$320.00+15.61%

Should I buy or sell CAH stock?

Based on 12 analysts offering ratings for Cardinal Health Inc.

Strong Buy
Strong Buy
7 analysts 58.33%
Buy
4 analysts 33.33%
Hold
1 analysts 8.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their CAH stock forecasts and price targets.

CAH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-11-10
lockedlocked$00.00+00.00%2026-11-09Find Out Why
lockedlocked$00.00+00.00%2026-11-06Find Out Why
lockedlocked$00.00+00.00%2026-11-06
lockedlocked$00.00+00.00%2026-10-30
Mizuho
Bottom 8%
8
BuyMaintains$280.00+1.16%2026-10-20
UBS
Top 10%
91
Strong BuyMaintains$295.00+6.58%2026-10-16
Barclays
Top 18%
83
Strong BuyMaintains$275.00-0.65%2026-08-13
Citigroup
Bottom 6%
6
Strong BuyMaintains$280.00+1.16%2026-08-12
Wells Fargo
Top 6%
95
Strong BuyMaintains$277.00+0.08%2026-08-12Find out why

1 of 2

Forecast return on equity

Is CAH forecast to generate an efficient return?

Company
-121.79%
Industry
-72.08%
Market
161.1%
CAH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CAH forecast to generate an efficient return on assets?

Company
6.19%
Industry
6.66%
CAH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CAH earnings per share forecast

What is CAH's earnings per share in the next 3 years based on estimates from 21 analysts?

Avg 1 year Forecast
$12.80+64.68%
Avg 2 year Forecast
$14.34+84.52%
Avg 3 year Forecast
$15.94+105.15%
CAH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

CAH revenue forecast

What is CAH's revenue in the next 3 years based on estimates from 19 analysts?

Avg 1 year Forecast
$268.7B+4.25%
Avg 2 year Forecast
$284.5B+10.37%
Avg 3 year Forecast
$300.8B+16.72%
CAH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CAH earnings growth forecast

How is CAH forecast to perform vs Medical Distribution companies and vs the US market?

Company
27.03%
Industry
18.87%
Market
32.59%
CAH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CAH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CAH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CAH revenue growth forecast

How is CAH forecast to perform vs Medical Distribution companies and vs the US market?

Company
5.27%
Industry
5.32%
Market
12.17%
CAH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CAH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CAH vs Medical Distribution Stocks

TickerPricePrice TargetUp/downsideConsensus
CAH$276.79$286.00+3.33%Strong Buy
COR$348.71$371.82+6.63%Strong Buy
HSIC$88.74$100.57+13.33%Strong Buy
MCK$1,082.59$1,102.30+1.82%Buy
AHG$1.25N/AN/A
View Top Medical Distribution Stocks

Cardinal Health Stock Forecast FAQ

Is Cardinal Health Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NYSE: CAH) stock is to Strong Buy CAH stock.

Out of 12 analysts, 7 (58.33%) are recommending CAH as a Strong Buy, 4 (33.33%) are recommending CAH as a Buy, 1 (8.33%) are recommending CAH as a Hold, 0 (0%) are recommending CAH as a Sell, and 0 (0%) are recommending CAH as a Strong Sell.

If you're new to stock investing, here's how to buy Cardinal Health stock.

What is CAH's earnings growth forecast for 2027-2029?

(NYSE: CAH) Cardinal Health's forecast annual earnings growth rate of 27.03% is forecast to beat the US Medical Distribution industry's average forecast earnings growth rate of 18.87%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.59%.

Cardinal Health's earnings in 2026 is $1,818,000,000.On average, 21 Wall Street analysts forecast CAH's earnings for 2027 to be $2,957,485,955, with the lowest CAH earnings forecast at $2,835,954,302, and the highest CAH earnings forecast at $3,155,015,341. On average, 20 Wall Street analysts forecast CAH's earnings for 2028 to be $3,313,875,564, with the lowest CAH earnings forecast at $3,003,574,604, and the highest CAH earnings forecast at $3,676,806,339.

In 2029, CAH is forecast to generate $3,684,272,053 in earnings, with the lowest earnings forecast at $3,302,572,981 and the highest earnings forecast at $3,985,027,069.

What is CAH's revenue growth forecast for 2027-2029?

(NYSE: CAH) Cardinal Health's forecast annual revenue growth rate of 5.27% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 5.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.17%.

Cardinal Health's revenue in 2026 is $257,752,000,000.On average, 19 Wall Street analysts forecast CAH's revenue for 2027 to be $62,106,881,471,810, with the lowest CAH revenue forecast at $59,896,059,366,735, and the highest CAH revenue forecast at $65,119,516,633,080. On average, 19 Wall Street analysts forecast CAH's revenue for 2028 to be $65,755,373,570,985, with the lowest CAH revenue forecast at $62,273,068,726,755, and the highest CAH revenue forecast at $71,105,724,860,925.

In 2029, CAH is forecast to generate $69,535,844,700,165 in revenue, with the lowest revenue forecast at $64,550,920,461,780 and the highest revenue forecast at $78,000,993,552,885.

What is CAH's forecast return on assets (ROA) for 2027-2029?

(NYSE: CAH) forecast ROA is 6.19%, which is lower than the forecast US Medical Distribution industry average of 6.66%.

What is CAH's Price Target?

According to 12 Wall Street analysts that have issued a 1 year CAH price target, the average CAH price target is $286.00, with the highest CAH stock price forecast at $320.00 and the lowest CAH stock price forecast at $260.00.

On average, Wall Street analysts predict that Cardinal Health's share price could reach $286.00 by Nov 10, 2027. The average Cardinal Health stock price prediction forecasts a potential upside of 3.33% from the current CAH share price of $276.79.

What is CAH's Earnings Per Share (EPS) forecast for 2027-2029?

(NYSE: CAH) Cardinal Health's current Earnings Per Share (EPS) is $7.77. On average, analysts forecast that CAH's EPS will be $12.80 for 2027, with the lowest EPS forecast at $12.27, and the highest EPS forecast at $13.65. On average, analysts forecast that CAH's EPS will be $14.34 for 2028, with the lowest EPS forecast at $12.99, and the highest EPS forecast at $15.91. In 2029, CAH's EPS is forecast to hit $15.94 (min: $14.29, max: $17.24).

What is CAH's forecast return on equity (ROE) for 2027-2029?

(NYSE: CAH) forecast ROE is -121.79%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.